Sanjivani Paranteral Ltd

NSE: SANJIVIN · BSE: 531569 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹179.85
Market cap: ₹220.9 Cr
Revenue (annual): ₹68.67 Cr
Net profit (annual): ₹6.79 Cr
P/E (TTM): 21.0×Sector 47.4×
Promoter holding: 31.56%+0.30% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 4 Other Announcement 3 Financial Results 3 Earnings Call 3 Board Meeting Date 3 Promoter Buying 2 Fund Raise 2 Results Update 1 Debt & Borrowing 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

23 Sep 2026 15:48 IST BSE

Fund RaiseAlfa Alert

Sanjivani Paranteral Fund Raise

Sanjivani Paranteral clarified the objects of its proposed 5 lakh convertible warrant issue to BSE. Proceeds of ~₹5.80 Cr will fund capex and subsidiary working capital for expansion.

Read the story on ALFA News Read the filing ↗

23 Jul 2026 22:57 IST BSE

Fund RaiseAlfa Alert

Sanjivani Paranteral Fund Raise of ₹7.37 Cr

Sanjivani Paranteral Ltd approved a preferential issue of 500,000 convertible warrants to Mr. Ashwani Khemka, raising ₹7.37 Crore. The issuance, set for an 18-month conversion window, strengthens capital.

Value: ₹7.37 Cr
Execution: 18 months

Read the filing ↗